Mottola Frank bought SUPN

September 12, 2025 · Form 4 insider transaction

Mottola Frank bought 5,000 shares of Supernus Pharmaceuticals, Inc. at $39.40 per share, a transaction worth $197.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.